The nanoparticulate formulation is developed for nasal administration for two different drugs and evaluated for pharmacokinetic and pharmacodynamic profiles in suitable animal models.
Nimodipine is poorly water soluble antihypertensive drug. Self emulsifying formulation, complex with beta cyclodextrin and liquisolid compacts were developed, evaluated and compared in suitable animal models.
